VistaGen Therapeutics, Inc. Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VistaGen Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VistaGen Therapeutics, Inc. for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 175,000 | 262,500 | 175,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.96 | 175,000 | 343,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 100,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.80 | 100,000 | 380,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 200,000 | 300,000 | 200,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.49 | 200,000 | 698,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 5,000 | 7,500 | 5,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 5,000 | 50,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 21,250 | 31,875 | 21,250 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 21,250 | 212,500 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 50,000 | 500,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 1,125 | 1,688 | 1,125 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 1,125 | 11,250 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 3,000 | 4,500 | 3,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 3,000 | 30,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 1.96 | 125,000 | 245,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 80,000 | 120,000 | 80,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 3.80 | 80,000 | 304,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 3.49 | 125,000 | 436,250 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 12,500 | 18,750 | 12,500 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 12,500 | 125,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 1,250 | 1,875 | 1,250 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 1,250 | 12,500 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.50 | 2,500 | 3,750 | 2,500 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 35,000 | 52,500 | 35,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 1.96 | 35,000 | 68,600 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 3.80 | 25,000 | 95,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 3.49 | 25,000 | 87,250 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 2,500 | 3,750 | 2,500 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 7,500 | 11,250 | 7,500 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 7,500 | 75,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 1,000 | 1,500 | 1,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 1,000 | 10,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.50 | 375 | 563 | 375 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | D | 10.00 | 375 | 3,750 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 100,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 1.96 | 100,000 | 196,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 3.80 | 50,000 | 190,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 75,000 | 112,500 | 75,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 3.49 | 75,000 | 261,750 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 1,000 | 1,500 | 1,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 8.00 | 1,000 | 8,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 4,323 | 6,485 | 4,323 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 10.00 | 4,323 | 43,230 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | A | 1.50 | 678 | 1,017 | 678 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | VP, CFO AND SECRETA ... | Option Exercise | D | 10.00 | 678 | 6,780 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 35,000 | 52,500 | 35,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 1.96 | 35,000 | 68,600 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 3.80 | 25,000 | 95,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 3.49 | 25,000 | 87,250 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | D | 8.00 | 25,000 | 200,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 250,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | D | 1.96 | 100,000 | 196,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | D | 3.80 | 40,000 | 152,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | D | 4.27 | 125,000 | 533,750 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 35,000 | 52,500 | 35,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 1.96 | 35,000 | 68,600 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 3.80 | 25,000 | 95,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 25,000 | 37,500 | 25,000 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 3.49 | 25,000 | 87,250 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 2,500 | 3,750 | 2,500 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 6,250 | 9,375 | 6,250 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 10.00 | 6,250 | 62,500 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.50 | 500 | 750 | 500 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | D | 10.00 | 500 | 5,000 | 0 | ||
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.50 | 125,000 | 187,500 | 125,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | D | 1.96 | 125,000 | 245,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.50 | 80,000 | 120,000 | 80,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | D | 3.80 | 80,000 | 304,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.50 | 180,000 | 270,000 | 180,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | D | 3.49 | 180,000 | 628,200 | 0 | |
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | GIN JERRY B | Option Exercise | A | 1.27 | 75,000 | 95,250 | 75,000 | ||
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | SAXE JON S | Option Exercise | A | 1.27 | 75,000 | 95,250 | 75,000 | ||
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | Underdown Brian J. | Option Exercise | A | 1.27 | 75,000 | 95,250 | 75,000 | ||
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | Smith Mark Alan | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 | |
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | MCPARTLAND MARK A. | VP CORPORATE DEVELO ... | Option Exercise | A | 1.27 | 150,000 | 190,500 | 150,000 | |
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | SNODGRASS H. RALPH | PRES./CHIEF SCIENTI ... | Option Exercise | A | 1.27 | 125,000 | 158,750 | 125,000 | |
| Aug 06 2018 | VTGN | VistaGen Therapeut ... | DOTSON JERROLD DUANE | CFO AND SECRETARY | Option Exercise | A | 1.27 | 100,000 | 127,000 | 100,000 |